openPR Logo
Press release

Cancer/Tumor Profiling Market with New Principle and Updated Strategies 2027 Illumina, Inc., Qiagen N.V., NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health, Caris Life Sciences, Helomics Corp

03-13-2019 04:07 PM CET | Health & Medicine

Press release from: The Insight Partners

Cancer/Tumor Profiling Market

Cancer/Tumor Profiling Market

Tumor profiling services use a variety of methods for the examination of patient's tumor. Some utilize next generation DNA sequencing or RNA sequencing, while others analyze protein expression. Multiple technologies are used to provide very specific information about the molecular and genetic makeup of the tumor. Tumor profiling companies utilize various methods to examine the biopsy sample, and return information about the genes altered in the cancer cells.

The cancer/tumor profiling market is expected to grow in the forecast period owing to key factors such as growing number of new cancer cases, rising utility of biomarkers in tumor profiling, and availability of funding for cancer research. The market is likely to experience the growth opportunities in the emerging nations and the technological advancements, increasing demand for point-of-care diagnostic tests are likely to develop innovative products.

Get PDF sample copy of research report: http://bit.ly/2INTonV

The "Global Cancer/Tumor Profiling Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global cancer/tumor profiling market with detailed market segmentation by technology, cancer type, application, and geography. The global Cancer/Tumor Profiling market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Cancer/Tumor Profiling market players and offers key trends and opportunities in the market.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cancer/tumor profiling market based on technology, cancer type and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer/tumor profiling market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the cancer/tumor profiling market in the forecast period due to presence of major players and rapid advances in technology, high prevalence of cancer and increased research in oncology to identify and discover innovative therapy for cancer treatment. Asia Pacific is anticipated to be the fastest growing region due to the increasing incidence of cancer, rising demand for better healthcare services in developing economies such as India and China, growing number of contract research organizations (CROs), and increasing focus of international players on emerging markets.

The report analyzes factors affecting cancer/tumor profiling market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cancer/tumor profiling market in these regions.

Top Key Players:
• Illumina, Inc.
• QIAGEN
• NeoGenomics Laboratories, Inc.
• HTG Molecular Diagnostics, Inc.
• Genomic Health
• Caris Life Sciences
• Helomics Corp.
• NanoString Technologies, Inc.
• Oxford Gene Technology
• Ribomed Biotechnologies, Inc.

Cancer/Tumor Profiling Market – Key Points Covered
• Key Facts
• Business Description
• Financial Overview
• Product Portfolio
• SWOT Analysis
• Key Developments

Reason to buy:
Save and reduce time carrying out entry-level research by identifying the market growth, size, leading players and segments in the global Cancer/Tumor Profiling market

highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Cancer/Tumor Profiling market, thereby allowing players across the value chain to develop effective long term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging market
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
• Examine the political, economic, social and technology impact of the five regions namely: north america, europe, asia pacific, middle east & africa and south & central america.

For More Statistical and Numerical Research
Get discount on this report@ http://bit.ly/2XDC4p6

The global cancer/tumor profiling market is segmented on the basis of technology, cancer type and application. Based on technology, the market is segmented as immunoassays, hybridization, sequencing techniques, mass spectrometry, and others. On the basis of cancer type, the cancer/tumor profiling market segmentation is classified as lung cancer, breast cancer, colorectal cancer, prostate cancer, melanoma cancer, and others. Based on the application the market is segmented as clinical application and research application.

Global Cancer/Tumor Profiling market - by geography

• NORTH AMERICA
• U.S.
• CANADA
• MEXICO

• EUROPE
• UK
• GERMANY
• FRANCE

• ASIA PACIFIC (APAC)
• JAPAN
• CHINA
• INDIA

• MIDDLE EAST & AFRICA (MEA)
• U.A.E
• SAUDI ARABIA
• SOUTH AFRICA

• SOUTH AND CENTRAL AMERICA (SCAM)
• BRAZIL

About us
The insight partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

The insight partners,
Call: +1-646-491-9876
email: sales@theinsightpartners.com
Website: http://www.theinsightpartners.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer/Tumor Profiling Market with New Principle and Updated Strategies 2027 Illumina, Inc., Qiagen N.V., NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health, Caris Life Sciences, Helomics Corp here

News-ID: 1652254 • Views: 747

More Releases from The Insight Partners

Strategy Consulting Market Outlook to 2025 - The Boston Consulting, A.T. Kearney …
The global strategy consulting market accounted to US$43.07 Bn in 2017 and is expected to grow at a CAGR of 9.9% during the forecast period 2018 - 2025, to account to US$91.38 Bn by 2025 Since decades, the consulting industry has imparted knowledge to the organizations where it is impacted owing to fundamental economic changes happening in the economy. The consulting industry used to work on the time based billing
Micromachining Market Major Manufacturers, Trends and Demand 2027 - Top Competit …
A new research report titled, ‘Micromachining Market’ has been added to the vast repository The Insight Partners. The intelligence report provides an in-depth analysis of the global market on the basis of the different types of products, technologies, industry verticals, applications, and end-users. The Micromachining Market Report is a valuable source of information for businesses and individuals. The technique used for the fabrication of 3D structures on the micrometer scale
Heat Recovery Steam Generator Market Estimated to Flourish by 2027 - Lead by Cle …
Worldwide Heat Recovery Steam Generator Market Analysis to 2027 is a specialized and in-depth study of the Heat Recovery Steam Generator Industry with a focus on the global market trend. The report aims to provide an overview of global Heat Recovery Steam Generator Market with detailed market segmentation by product/application and geography. The global Heat Recovery Steam Generator Market is expected to witness high growth during the forecast period. The
Portable Medical Devices Market Growing Technology Opportunities and Future Busi …
Allowing the access of patient data through various platforms and increasing demand for smart wearable devices is anticipated to offer more growth opportunities for the players operating in the portable medical devices market. Portable medical devices market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing demand for the real-time analysis, diagnosis, & monitoring and rising demand for emergency healthcare services

All 5 Releases


More Releases for Tumor

Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally. ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the
Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270 Tumor Ablation devices market
Global Tumor Ablation Devices Market - Insights
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators,
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Tumor Necrosis Factor Receptor
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed
Personalised tumor vaccines keep cancer in check
Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for